A Review on Host-Leptospira Interactions: What We Know and Future Expectations.

Leptospirosis is a widespread zoonosis caused by pathogenic Leptospira spp. It is considered a neglected infectious disease of human and veterinary concern. Our group has been investigating proteins annotated as hypothetical, predicted to be located on the leptospiral surface. Because of their location, these proteins may have the ability to interact with various host components, which could allow establishment of the infection. These proteins act as adherence factors by binding to host receptor molecules, such as the extracellular matrix (ECM) components laminin and glycosaminoglycans to help bacterial colonization. Leptospira also interacts with the host fibrinolytic system, which has been demonstrated to be a powerful tool for invasion mechanisms. The interaction with fibrinogen and thrombin has been shown to reduce fibrin clot formation. Additionally, the degradation of coagulation cascade components by secreted proteases or by acquired surface plasmin could also play a role in reducing clot formation, hence facilitating dissemination during infection. Interaction with host complement system regulators also plays a role in helping bacteria to evade the immune system, facilitating invasion. Interaction of Leptospira to cell receptors, such as cadherins, can contribute to investigate molecules that participate in virulence. To achieve a better understanding of the host-pathogen interaction, leptospiral mutagenesis tools have been developed and explored. This work presents several proteins that mediate binding to components of the ECM, plasma, components of the complement system and cells, to gather research achievements that can be helpful in better understanding the mechanisms of leptospiral-host interactions and discuss genetic manipulation for Leptospira spp. aimed at protein function validation.

Introduction

Leptospirosis is considered a neglected infectious disease of human and veterinary concern. The genus Leptospira includes both pathogenic and saprophytic species. The pathogenic group includes the causative agents of leptospirosis disease, while the saprophytic group consists of free-living non-disease-causing organisms. Leptospires can be genetically classified into 4 groups: P1 (pathogenic), P2 (intermediate) and S1 and S2 (saprophytic) (Vincent et al., 2019). They are also serologically divided, regarding serogroup and serovar status, associated with the antigenic heterogeneity of exposed lipopolysaccharides (LPSs) (Bharti et al., 2003). To date, more than 300 pathogenic serovars have been identified (Adler and de la Peña Moctezuma, 2010; Vincent et al., 2019). Human infection occurs mainly through direct contact with the urine or other biological fluids of infected animals or via indirect contact with contaminated soil or water (Levett, 2001; Bharti et al., 2003; Levett, 2015).

After contact with damaged skin or mucosa, pathogenic leptospires can rapidly penetrate and breach host biological barriers, being able to survive serum complement killing. They can reach target organs such as the liver, lungs and mainly the kidneys via the proximal tubules, within 1 hour of infection (Bharti et al., 2003), showing their high invasive potential (Haake and Levett, 2015).

The vaccines available for veterinary use are based on inactivated whole-cell or membrane preparations of pathogenic leptospires. These types of vaccines confer protective responses through, but not exclusively, the induction of antibodies against leptospiral LPS (de la Peña-Moctezuma et al., 1999; Naiman et al., 2002; Adler and de la Peña Moctezuma, 2010). However, these vaccines are not able to induce long-lasting protection and do not provide cross-protective immunity against leptospiral serovars not included in the vaccine preparation. A broad spectrum, cost-effective vaccine against leptospirosis is being pursued.

The number of genomes for which complete sequencing information is available has increased exponentially in the past two decades, including Leptospira spp. The available sequences combined with bioinformatics tools and DNA recombinant techniques have allowed the prediction of proteins in silico and their production in the laboratory, regardless of their abundance and without the need for manipulating the microorganism of study in vitro (Sette and Rappuoli, 2010). This has increased our understanding of the leptospiral pathogenic pathways, and the virulence factors involved, which many research groups have extensively investigated.

In the last years, several studies have revealed some outer membrane proteins of L. interrogans acting as adherence factors by binding to host receptor molecules. They can interact with components of the extracellular matrix (ECM) of host cells, such as laminin and glycosaminoglycans (GAGs). There are several ECM-binding proteins that potentially contribute to the leptospiral infection process (Vieira et al., 2014; Fernandes et al., 2016b). These leptospiral proteins also interact with plasma components such as plasminogen, plasmin, fibrinogen and thrombin. Another observed mechanism is the ability of these bacteria to interact with host complement system components such as C4b-binding protein (C4BP), factor H (FH), vitronectin and terminal complement components C7, C8 and C9, enabling them to survive serum attack (Cinco and Bandi, 1983; Meri et al., 2005; Verma et al., 2006; Barbosa et al., 2009; Silva et al., 2016; Siqueira et al., 2017). The process of how these interactions occur and their consequences are detailed throughout this article.

Identification and characterization of proteins that mediate the interactions with host components are essential for the understanding of leptospiral pathogenesis. Our research group has been particularly interested in proteins annotated as hypothetical, predicted to be located on Leptospira’s surface. Using these criteria, we gathered several leptospiral proteins that can potentially mediate the attachment of the bacteria to host components including ECM, plasma, complement system and host cells. Some of them are multifunctional, capable of binding to more than one component. The aim of this study was to put together research achievements that are helpful for further understanding the surface-exposed proteins that mediate leptospiral-host interactions and to ponder their possible significance for bacterial pathogenesis, as well discuss available genetic tools for the manipulation of Leptospira spp., with the aim of revealing protein function.

Binding of Leptospira to ECM and Cadherins

Laminin and E-Cadherin

Adhesive molecules present in bacterial systems can be divided into fimbriae and adhesins, the latter are capable of mediating bacterial adhesion to different elements on the surface of host cells and ECM (Pizarro-Cerdá and Cossart, 2006; Kline et al., 2009). Adhesins can be characterized as virulence factors, since they are responsible for the first steps of infection, contributing to the pathogenesis of various bacteria. Pathogenic Leptospira spp. have a great ability to promote infection because of their capacity to survive outside the host and the large number of susceptible mammals. One of the invasion strategies would be bacterial adhesion that recognizes components of the ECM and cell receptors such as laminin and e-cadherin, followed by cell invasion and colonization. Laminin is an adhesion glycoprotein present in the ECM of host cells, being found mainly in the basement membranes (Durbeej, 2010). Cadherins are extracellular calcium-dependent adhesion glycoproteins responsible for the formation of adherens junctions that enable the intercellular adhesion (Gallin, 1998). The structure of cadherins consists of and extracellular domain composed by five cadherin repeats responsible for Ca2+ binding, a transmembrane domain and a conserved intracellular domain (Marie et al., 2014).

Attachment of L. interrogans to laminin was demonstrated by microscopy in 2006 (Barbosa et al., 2006). Since then, several leptospiral proteins have been reported as laminin-exclusive ligands, and others have a broader range of host ligands. Lsa27 and LIC12796 are adhesins that, among all the possible components assayed, bind exclusively to laminin (Longhi et al., 2009; Lima et al., 2013). OmpL47 is an adhesin that binds to laminin, collagen III, fibronectin, aortic elastin and fibrinogen (Pinne et al., 2010). LigB is another broad-spectrum binding adhesin that interacts with collagen I, III and IV, laminin, fibronectin, elastin, tropoelastin, heparin, fibrinogen, FH, FHL-1, FHR-1 and C4bp (Choy et al., 2007; Lin et al., 2009; Castiblanco-Valencia et al., 2012; Ching et al., 2012). There are many leptospiral proteins described in the literature as laminin-binding (Choy et al., 2007; Atzingen et al., 2008; Hoke et al., 2008; Atzingen et al., 2009; Longhi et al., 2009; Oliveira et al., 2010; Vieira et al., 2010; Mendes et al., 2011; Domingos et al., 2012; Fernandes et al., 2012; Siqueira et al., 2013; Lima et al., 2013; Fernandes et al., 2014; Domingos et al., 2015; Passalia et al., 2020a).

Evangelista et al. (2014a) demonstrated that L. interrogans strongly binds to cadherin [vascular endothelial (VE-cadherin), epithelial (E-cadherin), neural (N-cadherin) and placental (P-cadherin) (Navarro et al., 1998; Prozialeck et al., 2004)]. There are a few L. interrogans proteins that have been described as cadherin-binding. For example, LIC11574 and LIC13411 are recombinant proteins that bind tightly to VE-cadherin (Evangelista et al., 2014b). The recombinant protein LIC10879, called Lsa16, interacts with E-cadherin, and when the protein is subjected to heat denaturation, binding increases. It has been suggested that unexposed amino acids on the secondary surface of Lsa16 also participate in this interaction (Pereira et al., 2017). The recombinant proteins LIC11711 and LIC12587 bind to laminin and E-cadherin, in addition to interacting with the fibrinolytic system (Kochi et al., 2019). It has been reported that virulent L. interrogans was able to maintain adhesion in renal proximal tubule epithelial cells, resulting in the E-cadherin cleavage and later its endocytosis with the release of the N-terminal fragment (cadherin domain repeats) into the extracellular medium (Sebastián et al., 2021).

The leptospiral proteins that exhibit features of binding to laminin, cadherin and other host ligands are listed in . It is anticipated that these proteins are possibly virulence factors for the maintenance of adhesion and infection processes of pathogenic leptospires in host cells. It is observed that Leptospira, like other pathogens (Isaacs, 1994; Breiner et al., 2009), has adhesin redundancy features, which is probably part of their invasion strategy. depicts the interactions of Leptospira with host components, cells and possible consequences.

Figure 1

Schematic view of colonization, invasion and evasion mechanisms displayed by pathogenic Leptospira. Leptospires can penetrate the host via breached skin or intact mucosa, taking advantage of many surface exposed proteins that are able to interact with a broad range of host components, including the extracellular matrix (ECM) components and glycosaminoglycans (GAGs). During the invasion process, leptospires can directly bind to ECM components and cell receptors, as cadherins, the latter favoring cell-cell integrity disruption (center). Leptospires interact with host plasminogen (PLG) (top and center) and induce the endothelial secretion of urokinase-type PLG activator (uPA), which in turn converts leptospires-bound PLG to its active form, plasmin (PLA). The latter, a broad-spectrum serine protease, is capable of degrading ECM components and immune mediators, as IgG and C3b, reducing opsonophagocytosis (top). One of the host mechanisms to block pathogen dissemination to other sites after endothelial lesion is the formation of fibrin clot, as a result of fibrinogen (Fg) cleavage by thrombin. In addition to Fg degradation by PLA, pathogenic Leptospira can also bind both Fg and thrombin, causing a bilateral obstruction of the fibrin clot reaction, favoring the dissemination step (left bottom), in association with ECM degradation by endogenous proteases and surface-associated PLA (center). Once in the bloodstream, leptospires must overcome one of the first lines of host defense, the complement, and this is achieved by a multitude of mechanisms, including binding to the negative complement regulators Factor H (FH) and C4 binding protein (C4BP), which participate in the degradation of C3b and C4b, respectively. Binding to terminal components C7, C8, C9 and vitronectin, would decrease membrane attack complex (MAC) formation (right bottom). Taken together, it is anticipated that these mechanisms will facilitate invasion and dissemination of Leptospira through the hosts.

Proteoglycans and Glycosaminoglycans in Leptospira Adhesion

Proteoglycans (PG) are complex macromolecules located in various animal tissues and have a broad distribution, as they are found within cells and at the cell membrane surface and ECM. They are composed of two structures: a core protein and long linear polysaccharides chain referred to as glycosaminoglycan (GAG). GAGs are composed of disaccharide repeats, usually hexoamine and uronic acid, where both units can be sulfated, increasing the PG density (Hay, 1991). Sulfation and composition of GAGs’ backbone influence their binding to several proteins and molecules with signal function, such as growth factors, cytokines, chemokines, morphogens, and enzymes (García et al., 2016). In the extracellular region, GAGs can modulate signaling by binding to those components and presenting them to their active site, acting in various cell processes such as cell adhesion, migration, proliferation, differentiation and morphogenesis, ECM assembly, tissue repair and inflammation (García et al., 2016). GAGs can also bind to microbial pathogens, an important step for bacterial adhesion to the host to facilitate invasion and colonization. Several studies have shown that mainly heparan sulfate but also chondroitin and dermatan sulfate is an important ligand for bacteria, viruses and parasites (Rostand and Esko, 1997; Shi et al., 2021).

The binding of Leptospira to PG and GAGs still lacks understanding about which adhesins are involved in the bacterial interaction with those components. It is already known that Leptospira can bind GAGs, and the binding pattern reveals that the connection is more efficient with chondroitin sulfate B (also known as dermatan sulfate) and C than heparan sulfate (Breiner et al., 2009). Contrasting with the spirochete Borrelia burgdorferi, Leptospira can bind to chondroitin sulfate C (Isaacs, 1994; Breiner et al., 2009). The influence of sulfation and polymer size was assessed by using dextran sulfate of different molecular weights, and it was shown that Leptospira had higher affinity to high molecular weight dextran sulfate. Therefore, the sulfation and size of PG polysaccharide chains are important characteristics for Leptospira attachment via GAG.

Breiner et al. (2009) and Martinez-Lopez et al. (2010) used mammalian cell cultures deficient in PG or mutant cell lines or α-galactosidase or β-xyloside to decrease cellular GAG levels; they showed that the adhesion of L. interrogans serovar Canicola and serovar Copenhageni to cells was partially inhibited. These results suggest that PG and GAGs play a role in Leptospira attachment to epithelial and endothelial cells; however, other receptors are also involved (Breiner et al., 2009; Martinez-Lopez et al., 2010). The adhesins LipL32, Loa22, OmpL1, p31/LipL45 and LenA were the first proteins described as GAG-binding proteins. From this group of proteins, only OmpL1 showed binding to heparin/heparan sulfate and chondroitin sulfate ABC (Robbins et al., 2015) ( ). LipL21 and LipL41, lipoproteins that are among the most expressed in the outer membrane, were also found to bind to GAGs. LipL21 showed a broad binding profile, by interacting with heparin/heparan sulfate and chondroitin sulfate, while LipL41 bound effectively to chondroitin 4 sulfate (Takahashi et al., 2021).

Cell Interactions and Adhesion

The adhesion of Leptospira to cell culture models has been investigated to examine localization in the host, adhesion characterization and signaling modifications and to analyze receptors and adhesins that participate in virulence. From the 1960s to 1990s, studies focused on determining the localization and cytotoxicity of Leptospira strains. In vitro cell culture started to be assessed using primary kidney cell culture, when studies showed that L. interrogans serovar Pomona bound more to fibroblasts than epithelial cells, and it was also observed that fibroblasts detached from the surface of flasks while epithelial cells remained adhered (Harrington and Sleight, 1966; Miller et al., 1966). Subsequently, several studies using cells from kidney proximal tubules showed bacterial adhesion to microvilli of those cells (Miller and Wilson, 1967; de Martino et al., 1969; Marshall, 1974; Sterling and Thiermann, 1981).

Localization assays not only referred to tissue specificity but indicated in which part of cell the interactions occurred. The first results suggested that Leptospira could be an intracellular pathogen in cell culture, as bacteria were found in the cytoplasm in microscopy assays (Rose et al., 1966; Vinh et al., 1984; Thomas and Higbie, 1990). However, an assay using translocation of polarized MDCK (Madin-Darby canine kidney) monolayer cells showed that the bacteria were invasive but not intracellular, and they were not found in intercellular junctions (Barocchi et al., 2002).

Virulent and saprophytic strains were compared regarding adherence to MDCK, L929 and other cultured kidney cells, as demonstrated by microscopy, and the virulent strains more than the saprophytic ones were found to be bound to the cells, while nonspecific adherence to plastic and glass surfaces occurred with the saprophyte L. biflexa (Tsuchimoto et al., 1984; Vinh et al., 1984; Ballard et al., 1986; Ito and Yanagawa, 1987). Later, during the 1990s, adhesion to epithelial and endothelial cells was quantified by radiolabeled bacteria, showing that pathogenic strains bound 1.8 to 5 times more than the saprophytic strains (Thomas and Higbie, 1990). Pathogenic Leptospira binding to PMN (polymorphonuclear) leukocytes and CHO (Chinese hamster ovary) mutants for Mac-1 (the CR3 integrin) was also demonstrated, indicating bacterial binding via integrins (Cinco et al., 2002). One study compared L. interrogans serovar Portlandvere and L. borgpetersenii serovar Jules in binding to HEp-2 (human epithelial) cells under different cell treatments (Andrade and Brown, 2012). Interestingly, Breiner et al. (2009) and Evangelista et al. (2014a) showed that L. interrogans bound more to cells than to ECM produced by cultured epithelial and endothelial cells (Breiner et al., 2009; Evangelista et al., 2014a).

The evaluation of cytotoxicity of Leptospira was assessed by the cytopathic effects induced by bacterial culture supernatant in cells (Miller et al., 1970; Yam et al., 1970; Finn and Jenkin, 1973). Other toxic effects of intact bacteria or membrane and secreted proteins were then observed in cell culture. Hemolysin SphH was able to form pores in erythrocytes, and there was lactate dehydrogenase release after 2 hours of incubation and cell lysis after 6-8 hours when using Vero, A529, H1299 and L132 cells (Lee et al., 2002). LipL32 showed the same cytotoxic profile when incubated with ECV304 cells by the release of lactate dehydrogenase and nitric oxide (Huang et al., 2008).

There are also several studies reporting an increase in PMN cell adherence and receptors in HUVEC (human umbilical vein endothelial) cells after stimulus with pathogenic bacteria, suggesting involvement in the inflammatory processes activation and host defense in vascular endothelium (Dobrina et al., 1995). Both virulent and saprophytic Leptospira, and the proteins LIC10365, LIC10507, LIC10508, LIC10509 and LIC12690 were also capable of stimulating HUVEC cells, as assessed by the increase in E-selectin and ICAM-1 receptors, which are involved in cell-cell and cell-ECM adherence and recruitment and migration of neutrophils to vascular endothelium (Vieira et al., 2007; Gómez et al., 2008; Atzingen et al., 2009). Another study observed an increase in von Willebrand factor when HUVEC cells were incubated with virulent bacteria, but no upregulation of E -selectin or ICAM-1 (Goeijenbier et al., 2015). The methods used were FACS and ELISA, which can produce differences in the detection of the receptors.

Modification of the cytoskeleton of cells was found in microarray and immunofluorescence using endothelial cells and virulent strains, showing a decrease in the expression of β-actin and of proteins involved in focal adhesions, leukocyte migration and ECM interaction pathways, suggesting that the virulent strain promotes actin remodeling and detachment of cells from ECM (Martinez-Lopez et al., 2010). The assays using immunofluorescence of endothelial cells were further investigated, showing morphological disruptions, as found in ZO-1 in tight junctions, and a decrease in the levels of VE-cadherin and catenins in adherence junctions was detected, indicating the VE-cadherin—catenin complex as a primary target for pathogenic L. interrogans (Sato and Coburn, 2017).

Receptors for adhesion to epithelial and endothelial cells were identified by assays using enzymes, lectins, integrins and saccharides (Cinco et al., 2002; Andrade and Brown, 2012). Assays using protein array technologies were an interesting tool to identify and screen receptors important to pathogen adherence. The evaluation of receptors by mass spectroscopy and protein array identified the family of cadherins as receptors for Leptospira, and in this work, several cell lines were evaluated and showed binding (Evangelista et al., 2014a). In phage display assays, LIC11574 showed binding to epithelial and endothelial cells, and also bound to VE-cadherin (Evangelista et al., 2014b), and LIC12976, a laminin-binding protein, bound to fibroblasts and epithelial cells (Lima et al., 2013). LIC10831 was also assessed as an E- and VE-cadherin ligand using different cell lines, including CHO mutants expressing the receptor and endothelial cells (Eshghi et al., 2019). The terminal repeats of the proteins LigA and LigB, which interacted with the gelatin binding domain of fibronectin, were able to bind to MDCK cells and inhibited the ligation of L. interrogans serovar Pomona to the monolayers (Lin et al., 2010). Also, LigB and a mutant of L. biflexa expressing LigA showed binding to human embryonic lung cells and these interactions were blocked in the presence of human tropoelastin up to 68% and 61%, respectively (Hsieh et al., 2017).

The major proteins from Leptospira, previously characterized as adhesins (LipL32, Loa22, OmpL1, p31/LipL45 and LenA) were evaluated in epithelial and endothelial cells, and only OmpL1 displayed a significant difference in binding to Hep-2 and EA.hy926 cells (Robbins et al., 2015).

Binding of Leptospira to Plasma Components

Leptospiral Proteins That Bind to Plasminogen

The interaction of Leptospira with the host fibrinolytic system has been demonstrated to be a powerful tool for invasion mechanisms. Plasmin is the major component of the fibrinolytic system, a broad-spectrum serine protease that is activated after plasminogen cleavage by tissue-type (tPA) or urokinase-type (uPA) plasminogen activator. Plasminogen is found in human tissues and plasma in high amounts; its structure contains five kringle domains, which mediate binding to several ligands via their lysine residues (Castellino and Ploplis, 2005). The ability of Leptospira spp. to bind plasminogen on its surface and convert it to plasmin in the presence of an exogenous activator, can provide leptospires with certain advantages. Leptospira associated with plasmin have the capacity to cleave ECM proteins and degrade complement components, such as C3b and IgG, interfering with the deposition of these molecules on the bacterial surface and consequently disrupting the opsonophagocytosis process, which facilitates bacterial immune evasion ( ) (Vieira et al., 2009; Vieira et al., 2011; Vieira et al., 2013; Verma et al., 2020)

In the last few years, several proteins experimentally described as located on the Leptospira surface have been identified as plasminogen-binding. Interactions have been demonstrated to occur mainly via the lysine residues in proteins and plasminogen kringle domains, since the interactions were inhibited by a lysine analog, as observed by in vitro assay (Domingos et al., 2012; Teixeira et al., 2015; Fernandes et al., 2016b; Vieira and Nascimento, 2016; Pereira et al., 2017; Passalia et al., 2020a; Passalia et al., 2021). Among many proteins already identified as a plasminogen receptor, the major outer membrane lipoproteins LipL32, LipL21 and LipL41 and the transmembrane protein OmpL1 are included (Fernandes et al., 2012; Vieira et al., 2010; Takahashi et al., 2021). As reported for the bacteria, plasminogen bound to recombinant proteins is converted to active plasmin in the presence of an exogenous activator. Also, proteins such as rLIC11711, rLIC13259, Lsa24.9, rLIC13086 and LipL41 were able to acquire plasminogen from human serum, suggesting the viability of these interactions under physiological conditions and their possible role in leptospiral virulence (Cavenague et al., 2019; Kochi et al., 2019; Rossini et al., 2020; Passalia et al., 2021; Takahashi et al., 2021). Leptospiral immunoglobulin-like proteins, known as Lig proteins, have also been identified as plasminogen-binding. It was observed that plasminogen bound to these proteins was converted to active plasmin and able to degrade fibrinogen and complement proteins C3b and C5 (Oliveira et al., 2013; Castiblanco-Valencia et al., 2016)

Although the major proteins identified as plasminogen-binding are described as being outer membrane or secreted proteins, cytoplasmic proteins have also been identified as plasminogen-binding (Vieira et al., 2012; Nogueira et al., 2013). Enolase is described as a metabolic enzyme, but in Leptospira, it was shown to be secreted and have the ability to interact with plasminogen (Nogueira et al., 2013). The role of cytoplasmic proteins in host-pathogen interactions is still undefined, but proteins such as DnaK, glutamine synthetase and acetyltransferase were also identified as plasminogen ligands (Vieira et al., 2012). It is speculated that, at some point, these proteins are exported to the bacterial surface or after cell lysis these proteins could find plasminogen, helping surviving cells to disseminate in host tissues.

Most of the plasminogen-binding proteins identified until now do not display exclusive interaction with this component. They have the ability to interact with other host components, which characterize them as multifunctional molecules. In contrast, some proteins such as LipL46, Lp30 and Lp49 show plasminogen-exclusive binding properties ( ) (Vieira et al., 2010; Oliveira et al., 2011; Santos et al., 2018). The reason why some proteins bind exclusively to plasminogen and others do not is still unclear. Thus, it is possible that the multiple binding characteristics observed by surface membrane proteins may contribute to leptospiral pathogenesis. The main features of proteins identified as plasminogen-binding and their interactions with other host molecules are summarized in .

Leptospiral Protein Interactions With Fibrinogen and Thrombin

Fibrinogen is a homodimeric glycoprotein complex synthetized primarily in hepatocytes, and it circulates in plasma at high concentrations (2-5 mg/mL) in healthy individuals. In coagulation, fibrinogen is enzymatically converted to insoluble fibrin by proteolytic cleavage of N-terminal fibrinopeptides mediated by thrombin. Clot formation, stability and structure are influenced by several factors such as concentrations of anticoagulants, procoagulants, metal ions and fibrinogen-binding proteins during fibrin formation (Doolittle, 1984; Weisel, 2005; Wolberg and Campbell, 2008).

Several bacterial pathogens have mechanisms to overcome clotting in the fibrinolytic system; this can be achieved through degradation of host components by secreting proteases or using host plasminogen (Lähteenmäki et al., 2001). Fibrinogen acts as the major component in clot formation during vascular injury and tissue damage, besides stopping bacterial dissemination (Chierakul et al., 2008; Wagenaar et al., 2010). It has been reported that pathogenic Leptospira spp. are able to bind either fibrinogen or thrombin, promoting a bilateral obstruction, thereby reducing fibrin clot formation. Additionally, the degradation of coagulation cascade components by secreted proteases or by acquired surface plasmin could also play a role on reducing clot formation, thereby facilitating dissemination during the establishment of infection. In leptospirosis patients, activated coagulation is observed, with increased levels of fibrin degradation products and plasma fibrinogen and reduced levels of antithrombin, associated with tissue damage and vascular injury ( ) (Oliveira et al., 2013; Fernandes et al., 2015; Fernandes et al., 2016a).

The interaction of Leptospira spp. with fibrinogen is mediated by several outer membrane proteins. To date, the fibrinogen-binding proteins identified include: LigA and LigB (Choy et al., 2011; Lin et al., 2011), OmpL37 (Pinne et al., 2010), Lsa33, Lsa25, Lsa30 and OmpL1 (Oliveira et al., 2013), Lsa23, Lsa36 (Siqueira et al., 2013), Lsa37 (Silva et al., 2016), rLIC10508 (Siqueira et al., 2015), Lsa25.6 and Lsa16 (Pereira et al., 2017), ErpY (Ghosh et al., 2019), rLIC10774 (Passalia et al., 2020a), and rLIC13086 (Passalia et al., 2021). The interactions with most of these proteins were found to be dose-dependent and specific. The inhibitory effect of fibrin clot formation was, however, only observed with LigB fragment 9-11 (Choy et al., 2011) and LigBCen2 (amino acids 1014–1165 of LigB) (Lin et al., 2011), Lsa33, rLIC12238, Lsa36, OmpL1, Lsa37, Lsa25.6, ErpY and rLIC13086 ( ), and it was incomplete, reaching a maximum of 90%. Although these results differ from other bacterial fibrinogen-binding proteins, ClfA of Staphylococcus aureus (Liu et al., 2005) and SdrG of Staphylococcus epidermidis (Davis et al., 2001), leptospires may use their redundant multifunctional proteins to overcome the clotting barrier.

Leptospires can interact with different components of the fibrinolytic system during the dissemination process. The binding to thrombin, observed to a higher degree in virulent strains, followed by culture-attenuated ones, occurs via the substrate-binding exosite I, and it was demonstrated that fibrin clotting is inhibited (Fernandes et al., 2015). The only reported protein to bind thrombin was LIC10774, but this interaction did not block clot formation. Additionally, leptospiral BatA and the serine protease BatB proteins were able to cause a disorder in platelet aggregation, another mechanism that leptospires can overcome in blood to disseminate (Fang et al., 2018; Passalia et al., 2020b).

Components of Complement System

The complement system is considered one of the first lines of defense against invading microorganisms because of its opsonic, inflammatory and lytic capacities. Complement effector functions result from the activation of three different pathways: classical, alternative, and/or lectin pathways (CP, AP and LP, respectively). Once activated, C5b initiates the terminal pathway and allows the association of C6 and C7 molecules. Component C7 is inserted into the lipid bilayer of the microorganism membrane and the interaction of C8 leads to stability of the C5b-7 complex. The association of several C9 molecules forms MAC, generating the C5b-9 complex and subsequently causing cell lysis (Kim and Song, 2006; Ricklin et al., 2010).

It has been shown that L. biflexa is rapidly killed in the presence of normal human serum (NHS), while pathogenic species are able to resist serum attack (Cinco and Bandi, 1983; Meri et al., 2005). This is due to the ability of these bacteria to interact with host complement system regulators, such as FH (Meri et al., 2005; Verma et al., 2006), C4BP (Barbosa et al., 2009), vitronectin (da Silva et al., 2015) and terminal complement components C7, C8 and C9 ( ) (Siqueira et al., 2017).

Several leptospiral proteins have been identified as FH and C4BP receptors. Endostatin-like (Len) proteins A (LenA) and B (LenB) (Stevenson et al., 2007), EF-Tu protein (Wolff et al., 2013) and Erp-Y-like lipoprotein (Ghosh et al., 2019) were identified as ligands of FH. Among these proteins, only LenA and EF-Tu showed the ability to inactivate C3b. The interaction with C4BP was demonstrated by Lsa30 (Souza et al., 2012), rLIC10774 (Passalia et al., 2020a) and rLIC13086 (Passalia et al., 2021), but only Lsa30 was assayed and shown to mediate C4b inactivation (Souza et al., 2012). Several proteins were able to interact with both regulators and inactivate C3b and C4b, such as the LigA and LigB (Castiblanco-Valencia et al., 2012), LcpA (da Silva et al., 2015), enolase (Salazar et al., 2017) and Lsa23 (Siqueira et al., 2016; Siqueira et al., 2017). The fine mapping of the interaction between C4BP and outer membrane proteins, LigA and LigB was assessed by Breda et al. (2015). The fragments LigA7-8, LigA9-10, LigA10-11, LigB7-8, LigB9-10 and LigB11-12 were able to interact with host protein.

In addition to binding to FH and C4BP, LcpA also interfered with the complement cascade by interacting with vitronectin and preventing C9 polymerization and MAC formation (da Silva et al., 2015). In the same way, Lsa23 was also able to interact with terminal complement components C8 and C9 (Siqueira et al., 2017), while rLIC10774 (Passalia et al., 2020a) and rLIC13086 were able to bind to C7, C8 and C9, and rLIC13086 also could recruit these components directly from NHS (Passalia et al., 2021). Furthermore, rLIC11711 exhibited binding to vitronectin and C8 (Kochi et al., 2019), while rLIC12587 and rLIC13259 showed binding to vitronectin, C7, C8 and C9 (Kochi et al., 2019; Cavenague et al., 2019). The recombinant proteins were able to capture the complement system components from NHS, and inhibit MAC formation, thus possibly contributing to leptospiral immune evasion ( ) (Cavenague et al., 2019; Kochi et al., 2019).

Mutagenesis in Leptospira spp. for Protein Function Validation

Properties displayed in vitro by purified recombinant protein do not necessarily reflect the native counterpart role in Leptospira spp. Accordingly, functional genomic and host-pathogen interaction analysis require genetic mutations in particular genes to assess the resulting phenotype (Shapiro et al., 2018). Gene knockout or knockdown in pathogenic species of Leptospira should ideally lead to a loss of function phenotype, which can be measured by interaction assays with purified host ligands and/or cultured cells, translocation assays or even challenge with host serum, for evaluating the outcome of leptospiral binding to complement regulators. On the other hand, the expression of pathogen-specific genes in the saprophyte L. biflexa has offered an alternative for studying protein function by gain-of-function phenotypes and, in some cases, has offered a complementation to results obtained by L. interrogans mutants ( ).

Figure 2

Genetic tools and mutant evaluation of Leptospira. As the saprophytic L. biflexa lacks most of the virulence-associated proteins, it is used as a surrogate for the expression of pathogen-specific proteins and gain-of-function phenotype evaluation. Increased binding to ECM and plasma components has been observed in recombinant L. biflexa expressing L. interrogans proteins. Contrarily to this strategy, knockout (KO) or knockdown (KD) in the pathogenic L. interrogans has been used to evaluate loss-of-function phenotypes, in comparison to the wild-type strain. Reduced virulence in animal model was observed for KD double LigA/LigB, KO Loa22 and KO Mce mutants. KO of LipL32, the major lipoprotein of pathogenic leptospires, did not alter virulence or ECM binding.

The application of mariner-based transposon mutagenesis revealed Loa22 as a virulence factor of Leptospira since the transposon disruption in the loa22 gene resulted in an avirulent mutant (Ristow et al., 2007). Likewise, disruption of the flaA1 and flaA2 genes or just flaA2 resulted in reduced bacterial motility and less virulent mutant strains, indicating that motility is associated with leptospiral invasion (Lambert et al., 2012).

Mutation in the surface-exposed LruA resulted in attenuation of the virulence of L. interrogans compared to the wild-type strain in a hamster model of infection (Zhang et al., 2013). Interestingly, mutations in the genes encoding the L. interrogans serovar Manilae proteins LipL32 (Murray et al., 2009) and LipL41 (King et al., 2013), two of the most abundant and highly conserved outer membrane proteins in pathogenic Leptospira species, did not alter leptospiral virulence or symptoms of acute leptospirosis in infected hamsters. Accordingly, the lipL32 mutant displayed no difference in binding to a commercially available ECM preparation, laminin or collagen type I, in comparison to a control intergenic mutant (Murray et al., 2009), highlighting the functional redundancy displayed by leptospires. Binding assays were not performed for the lipL41 mutant (King et al., 2013).

Croda et al. (2008) performed site-directed mutation in pathogenic Leptospira by allelic exchange, utilizing a suicide plasmid to deliver a spectinomycin resistance cassette flanked by two “homology arms” corresponding to the ligB coding region. In vitro adherence of the ligB mutant to MDCK monolayers showed no difference between this and the wild-type strain. Accordingly, disruption of ligB did not affect virulence and persistence in animal models, probably because of functional redundancy to the ligA gene product.

Site-directed inactivation of the mce (mammalian cell entry, LA2055, homologous to LIC11859) in L. interrogans serovar Lai by Zhang et al., 2012 resulted in significantly diminished adherence invasion of murine J774A.1 macrophages in comparison to wild type strain; attenuation of virulence was also observed for the mce knockout mutant.

Pappas and Picardeau (2015) used a transposon-delivered cassette containing the Xanthomonas transcription activator-like effector (TALE) targeting both ligA and ligB genes, aiming the blockage of gene transcription (knockdown), thereby reducing but not abolishing the levels of LigA and LigB proteins. Though the authors did not perform any functional characterization of the mutants regarding interaction with host components, attenuation in the hamster model could be observed, indicating that both proteins are required for virulence (Pappas and Picardeau, 2015).

Concomitant and complete silencing of both LigA and LigB proteins by CRISPR-interference (CRISPRi) resulted in a drastic reduction of L. interrogans survival upon serum challenge, corroborating their interaction with complement regulators (Fernandes et al., 2021). In addition, this augmented serum susceptibility resulted in avirulent leptospires (Fernandes et al., 2021, manuscript in preparation), as previously demonstrated (Pappas and Picardeau, 2015).

Results obtained with mutants in L. interrogans agreed with the phenotypes observed by expression in the surrogate L. biflexa, favoring the elucidation of the complement resistance displayed by pathogenic leptospires and how LigA and LigB proteins fit in the scenario. L. biflexa individually expressing LigA or LigB gained the ability to sequester the negative complement regulators FH and C4BP, which retained the cofactor activity on the leptospiral surface. As a result, the recombinant L. biflexa displayed enhanced survival upon human serum challenge (Castiblanco-Valencia et al., 2016).

Zhang et al. (2012) used L. biflexa expressing the Mce protein to confirm the results obtained with the allelic exchange mutant in L. interrogans, showing that the recombinant bacteria displayed increased capacity for binding to murine macrophages. In addition, the heterologous expression of lmb216 (under lipL32 promoter) and ligB (under borrelial flaB promoter) in L. biflexa resulted in enhanced adhesion to fibronectin and phagocytic uptake, confirming the results obtained with the respective transposon mutants in L. interrogans (Toma et al., 2014).

The L. biflexa surrogate system was also employed to validate Lig protein binding to ECM molecules and host cells (Figueira et al., 2011). Constitutive expression of LigA driven by the borrelial flgB promoter resulted in enhanced adherence of the recombinant bacteria to MDCK cells, in comparison to the wild-type strain; neither LigA nor LigB expression influenced the bacterial translocation across MDCK monolayers. Recombinant L. biflexa expressing LigA or LigB displayed increased interaction with plasma and cellular fibronectin and laminin but not with elastin or collagens (Figueira et al., 2011), and also enhanced binding to human fibrinogen (Choy et al., 2011).

Overexpression of the pathogen-specific LIC11711 gene by genetic fusion of the coding sequence to the strong and constitutive lipL32 promoter strengthened the adhesin properties displayed by the recombinant counterpart according to in vitro assays, since this protein was suggested to be involved in leptospiral binding to laminin and plasminogen (Kochi et al., 2019). L. biflexa expressing LIC11711 on its surface showed increased binding to laminin and plasminogen compared to the wild-type or empty plasmid-containing strains. LIC11711-bound plasminogen was capable of being converted to plasmin in the presence of uPA (Kochi et al., 2020), where this was the first time that a mutant was used to validate a leptospiral plasminogen receptor ( ).

Concluding Remarks

We offer here an overview of many proteins possibly involved in the pathogenesis of Leptospira. The interaction of these proteins with ECM components can mediate the attachment of Leptospira to mammalian host cells, starting the process of invasion/colonization. Some proteins bind plasminogen at the bacterial surface, which is then converted to plasmin; surface plasmin gives the bacteria proteolytic capability, contributing to the invasion process. In addition, surface plasmin prevents C3b and IgG deposition on the leptospiral surface, reducing opsonophagocytosis. Pathogenic Leptospira spp. can also bind fibrinogen and thrombin, causing a bilateral obstruction and reduction of fibrin clot formation, leading to possible hemorrhage foci. In addition, these bacteria can resist serum attack, which has been linked to their ability to interact with host complement system components, namely C4BP, FH, vitronectin, C7, C8 and C9, contributing to immune evasion. The adhesion of Leptospira to cell culture models to investigate localization in the host has contributed to determining receptors and adhesins that are involved in virulence.

We highlight the progress in the arsenal of genetic tools now available for gene knockout or knockdown in Leptospira spp., both pathogenic and saprophytic. These advances in confluence with the numerous data on recombinant proteins will greatly expand our understanding of the host-pathogen interaction. With the constantly increasing available data on leptospiral host-pathogen interaction, it became yet more evident how multifunctional these pathogens are, illustrated by not only the vast range of pathophysiologic mechanisms that they participate, but also by the numerous and redundant surface bacterial receptors. As future expectations, application of genetic tools to demonstrate “true” virulence determinants amongst all described leptospiral adhesins will narrow down the array of vaccine candidates. Due to the established leptospiral functional plasticity, it is anticipated that the best strategy will be merging these adhesins, proved to be required for virulence, as chimeric constructions, ultimately leading to a more rational vaccine development for controlling leptospirosis.

Author Contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work, and approved it for publication.

Funding

The following Brazilian agencies: FAPESP (grant 2019/17488-2), CNPq (grant 301229/2017-1) and Fundação Butantan, financially supported this work; AT, MC, LK, EF, LF, FP, MT, and BD have FAPESP fellowship (2016/11541-0; 2018/08131-0; 2018/09652-4; 2018/06201-1; 2017/06731-8; 2017/01102-2; 2017/26223-7; 2018/21959-8, respectively). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.